BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3797338)

  • 1. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors.
    Fahrenkrug J; Pedersen JH
    Peptides; 1986; 7(5):717-21. PubMed ID: 3797338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
    Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
    Fahrenkrug J
    Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans.
    Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects.
    Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B
    Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions.
    Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD
    Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin.
    Yasuda M; Minamitani N; Maeda K; Chihara K; Fujita K; Kobayashi I
    Regul Pept; 1993 Jul; 46(3):565-73. PubMed ID: 8210516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract.
    Palle C; Ottesen B; Jørgensen J; Fahrenkrug J
    Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule.
    Yiangou Y; Christofides ND; Blank MA; Yanaihara N; Tatemoto K; Bishop AE; Polak JM; Bloom SR
    Gastroenterology; 1985 Sep; 89(3):516-24. PubMed ID: 3839480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
    Mikkelsen JD; Fahrenkrug J
    Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide.
    Watanobe H; Takebe K
    Neuropeptides; 1992 Oct; 23(2):115-9. PubMed ID: 1333573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia.
    Watanobe H; Tamura T; Takahashi K
    Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
    Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain.
    Fahrenkrug J; Emson PC
    J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man.
    Fahrenkrug J; Pedersen JH; Yamashita Y; Ottesen B; Hökfelt T; Lundberg JM
    Regul Pept; 1987 Jul; 18(1):51-61. PubMed ID: 3306816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide and peptide histidine methionine. Presence in human follicular fluid and effects on DNA synthesis and steroid secretion in cultured human granulosa/lutein cells.
    Gräs S; Ovesen P; Andersen AN; Sørensen S; Fahrenkrug J; Ottesen B
    Hum Reprod; 1994 Jun; 9(6):1053-7. PubMed ID: 7962375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization.
    Bredkjaer HE; Wulff BS; Emson PC; Fahrenkrug J
    Cell Tissue Res; 1994 May; 276(2):229-38. PubMed ID: 8020060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide histidine valine (PHV) is present and biologically active in the human female genital tract.
    Palle C; Ottesen B; Fahrenkrug J
    Regul Pept; 1992 Mar; 38(2):101-9. PubMed ID: 1574604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.